3D Cell Cultures: Technologies and Global Markets

Summary Table: Global Market for 3D Cell Culture, by Segment, Through 2028
Table 1: Dimensionality of Cell Culture
Table 2: WHO R&D Roadmap of Priority Infectious Diseases
Table 3: 3D Bioprinting Roadmap
Table 4: Selected Online Prices for Bioreactors
Table 5: Global Market for 3D Cell Culture, by Segment, Through 2028
Table 6: Tissue Types
Table 7: Cell Types Based on Developmental Origin
Table 8: Leading Cell Line Suppliers, April 2020
Table 9: Commonly Used Transformed Cells Lines
Table 10: Major Primary Cell Lines
Table 11: Leading Primary Cell Suppliers
Table 12: Main Types of Stem Cells
Table 13: Stem Cell Services
Table 14: Areas of Interest in 3D Spheroid Research
Table 15: Selected Nanoparticle Products Used in Life Science Research
Table 16: Results of Liver-Chip Drugs Halted in Previous Clinical Trials Based on Animal Studies
Table 17: Companies and Universities Involved in the Organ-on-a-Chip Industry
Table 18: Microfluidics Companies
Table 19: Selected Recent Patents Issued on Microfluidic Devices Related to Cell Culture Applications
Table 20: Selected Papers Published on Recent Microfluidic Advances in Cell Culture
Table 21: High-Content Screening Suppliers and Key Attributes
Table 22: Selected Patents Issued Related to Flow Cytometers
Table 23: Thermo Fisher Imaging Products
Table 24: Recent Bioprinting Company Deals and Strategic Partnerships
Table 25: Bioprinting Modalities
Table 26: Maintaining Cell Viability During Printing
Table 27: Bioprinting Instrument Industry
Table 28: Biomaterial Components
Table 29: Bioink Types
Table 30: Classes of Matrix Bioink Hydrogels
Table 31: Matrix Bioink Selection Criteria
Table 32: Selected Bioink Companies, 2020
Table 33: Projected Unit Sales of Research Bioreactors, < 10 Liters, 2020
Table 34: Leading Bioreactor Suppliers, 2020
Table 35: Label-Free Technologies and Suppliers
Table 36: Developmental Issues Facing the Commercialization of Exosomes
Table 37: Companies Working on Exosome Products
Table 38: Global Market for Cell Culture, by End User, Through 2028
Table 39: Global Market for Cell Culture, by Application, Through 2028
Table 40: Global Market for Cell Culture, by Region, Through 2028
Table 41: Typical Assay Endpoints and Tests
Table 42: U.S. Patents on Assays Systems, 2019 and 2020
Table 43: Selected U.S. Patents on Assay Imaging, 2019 and 2020
Table 44: Recently Issued U.S. Patents on Cellomics, 2019
Table 45: Toxicology Issues That Need to Be Addressed for FDA-Regulated Products
Table 46: Overview of Federal Regulation of the Cell Culture Markets
Table 47: FDA List of Cell, Biologic and Tissue Products Regulated Under CBER and CDRH
Table 48: FDA “Talking Point” Recommendations for Regenerative Medicine Advanced Therapies (RMATs)
Table 49: U.S. Regulatory Considerations for Bioprinted Biologics
Table 50: Main Types of Models for Researching Cancer and Other Diseases
Table 51: Goals of Funding Opportunity Announcement RFA-CA-19-055
Table 52: Common 3D Assays
Table 53: Summary of the Benefits and Advantages of EV3D
Table 54: ECVAM List of Current Activities, 2020
Table 55: In Vitro Testing in Cosmetics, by Test Class
Table 56: Global Market for Cell Culture by Region, Through 2028
Table 57: North American Market for Cell Culture by Country, Through 2028
Table 58: European Market for Cell Culture by Country, Through 2028
Table 59: Asia-Pacific Market for Cell Culture by Country, Through 2028
Table 60: RoW Market for Cell Culture by Region, Through 2028
Table 61: Major and Minor Research Areas in Stem Cells
Table 62: Stem Cell Usage in Research
Table 63: Recent U.S. Patents Granted on Stem Cell Technologies
Table 64: Papers Published on Selected Stem Cell Research Trends
Table 65: Comparison of the Number of Citations in the Literature on Cell Culture versus Stem Cell Culture
Table 66: Number of Organ Transplants Performed in the United States, 2018 and 2019
Table 67: Total Global Financing of Regenerative Medicine
Table 68: Total Financing of Regenerative Medicine, by Therapeutic Area
Table 69: Leading Tissue Products and Suppliers
Table 70: Printed Tissue and Organs: Commercialization Timeframe
Table 71: Tissue/Organ Complexity
Table 72: 3D Bioprinting Solutions: Company Snapshot
Table 73: 3D Biotek LLC: Company Snapshot
Table 74: 4D Technology Corp.: Company Snapshot
Table 75: Abcam Plc: Company Snapshot
Table 76: Abcam PLC: Financial Performance, 2022
Table 77: Akron Biotech: Company Snapshot
Table 78: Agilent Technologies: Company Snapshot
Table 79: Agilent Technologies Inc.: Financial Performance, 2022
Table 80: Alpco: Company Snapshot
Table 81: Amsbio: Company Snapshot
Table 82: Beckman Coulter: Company Snapshot
Table 83: Bioinspired Solutions: Company Snapshot
Table 84: BioTime Inc.: Company Snapshot
Table 85: Biovision Inc.: Company Snapshot
Table 86: Cell Applications Inc.: Company Snapshot
Table 87: Cellink: Company Snapshot
Table 88: Corning Inc.: Company Snapshot
Table 89: Corning Inc.: Financial Performance, 2022
Table 90: Cyprotex: Company Snapshot
Table 91: Cytiva: Company Snapshot
Table 92: Cytoo SA: Company Snapshot
Table 93: Merck KGAA: Company Snapshot
Table 94: Merck KGAA: Financial Performance, 2022
Table 95: Emulate Inc.: Company Snapshot
Table 96: EnvisionTec Inc.: Company Snapshot
Table 97: Epithelix: Company Snapshot
Table 98: Greiner Bio-One International GmbH: Company Snapshot
Table 99: Hamilton Robotics: Company Snapshot
Table 100: HUB Organoids: Company Snapshot
Table 101: Hurel Corp.: Company Snapshot
Table 102: Insphero: Company Snapshot
Table 103: Invitrocue: Company Snapshot
Table 104: Kiyatec Inc.: Company Snapshot
Table 105: LifeNet Health: Company Snapshot
Table 106: Cytori Therapeutics Inc.: Company Snapshot
Table 107: Mattek: Company Snapshot
Table 108: Mimetas Inc.: Company Snapshot
Table 109: Organovo Holdings Inc.: Company Snapshot
Table 110: PerkinElmer Inc.: Company Snapshot
Table 111: Plasticell Ltd.: Company Snapshot
Table 112: Pluristem Therapeutics Inc.: Company Snapshot
Table 113: Poietis: Company Snapshot
Table 114: Promega Corp.: Company Snapshot
Table 115: SeaHorse Bioscience: Company Snapshot
Table 116: Stemcell Technologies: Company Snapshot
Table 117: Stratatech Corp.: Company Snapshot
Table 118: Synvivo Inc.: Company Snapshot
Table 119: Tap Biosystems: Company Snapshot
Table 120: Tecan Trading AG: Company Snapshot
Table 121: Zen-Bio Inc.: Company Snapshot

Summary Figure: Global Market for 3D Cell Culture, by Segment, 2020-2028
Figure 1: Research Chain for Cell Culture
Figure 2: A Model for The Evolution of FDA Regulation
Figure 3: 3D Cell Cultures: Market Dynamics
Figure 4: An Innovation Matrix
Figure 5: Bioprinting Strategic Roadmap
Figure 6: Global Market Shares of 3D Cell Culture, by Segment, 2022
Figure 7: Gastrointestinal Organotype Cultures
Figure 8: iCELLis Nanoreactor: Example of Commercial 2D Cell Culture Systems
Figure 9: Prototype of 3D Model Lung-on-a-Chip from Wake Forest
Figure 10: Recent Photo of the HepaChip
Figure 11: Recent Photo of the HepaChip-MWP
Figure 12: University of Toronto Handheld Bioprinting Device
Figure 13: Collaborative Experiment Conducted by American, Russian and Israeli Scientists
Figure 14: Smart Marbles Concept for Quantifying Process Heterogeneity
Figure 15: Porcine Intestinal Organoids
Figure 16: Diagram of the Components of a Predictive Toxicology System
Figure 17: Gleason’s Pattern
Figure 18: Diagram of PDXs, Cell Lines and Organoid/Spheroid Xenografts
Figure 19: Cell Heterogeneity and Its Function
Figure 20: Global Market for Cell Culture by Region, 2020-2028
Figure 21: North American Market for Cell Culture by Country, 2020-2028
Figure 22: European Market for Cell Culture by Country, 2020-2028
Figure 23: Asia-Pacific Market for Cell Culture by Country, 2020-2028
Figure 24: ROW Market for Cell Culture by Region, 2020-2028
Figure 25: Electron Micrograph of Porous Microcarrier for Stem Cell Production
Figure 26: Photograph of Apligraf
Figure 27: Abcam PLC: Financial Performance, 2021 and 2022
Figure 28: Abcam PLC: Revenue Shares, by Country/Region, 2022
Figure 29: Agilent Technologies Inc.: Financial Performance, 2021 and 2022
Figure 30: Agilent Technologies Inc.: Revenue Shares, by Business Unit, 2022
Figure 31: Agilent Technologies Inc.: Revenue Shares, by Country/Region, 2022
Figure 32: Corning Inc.: Revenue Shares, by Business Unit, FY 2022
Figure 33: Corning Inc.: Revenue Shares, by Region, FY 2022
Figure 34: Merck KGAA: Revenue Shares, by Business Unit, FY 2022
Figure 35: Merck KGAA: Revenue Shares, by Region, FY 2022